Skip to main content

Table 1 Patients characteristics

From: Basal cytokines profile in metastatic renal cell carcinoma patients treated with subcutaneous IL-2-based therapy compared with that of healthy donors

Characteristics

 

Median ECOG PS (range; PS 0/1/2)

1 (0–2; 10/40/5)

Median age (range)

62 (27–82)

Sex

 

   men (%)

35 (64%)

   woman (%)

20 (36%)

Disease site (%)

 

   Brain

2 (4%)

   Bone

11 (20%)

   Liver/viscera

23 (43%)

   Soft tissue/lung

18 (33%)

Pts metastatic sites (%)

 

   1

16 (30%)

   > 1

39 (70%)

Median Disease Free Interval (range)

4 (0–240)

Nephrectomy (%)

 

   Yes

50 (91%)

   No

5 (9%)